lumos.png
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
May 09, 2024 14:51 ET | Lumos Pharma, Inc.
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report first...
Phathom_Pharm_Logo_RGB.jpg
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024 08:00 ET | Phathom Pharmaceuticals
Over 17,500 total prescriptions for VOQUEZNA® products have been dispensed, launch-to-date, a 361% increase since last quarterly report Net revenues of $1.9 million reported for the first full...
AssemblyBio_logo_RGB.png
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
May 08, 2024 16:05 ET | Assembly Biosciences, Inc.
Clinical trial application clearances received for a Phase 1a/1b trial for ABI-5366 targeting recurrent genital herpes, and a Phase 1b trial for ABI-4334 in chronic HBV infection; both studies on...
MannkindLogoStackedPreferd.jpg
MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
May 06, 2024 06:05 ET | MannKind
MANNKIND RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR CLOFAZIMINE INHALATION SUSPENSION FOR THE TREATMENT OF SERIOUS LUNG DISEASE
Global Interstitial Cystitis Drugs Market
Interstitial Cystitis Drugs Global Market Report 2024, By Drugs (Pentosan Polysulfate Sodium; Dimethyl Sulfoxide), By Type (Oral Therapy; Intravesical Therapy) and By Distribution Channel
May 06, 2024 04:06 ET | Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Interstitial Cystitis Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The interstitial cystitis drugs...
Global Migraine Drugs Market
Global Migraine Drugs Market Report 2024, By Drug Class (Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants), By Route of Administration (Oral, Injectable) and By End-User
May 06, 2024 04:05 ET | Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Migraine Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The migraine drugs market size has grown strongly...
full_colour.png
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024 07:00 ET | GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...
Global Fill Finish Manufacturing Market
Global Fill Finish Manufacturing Market Report 2024-2029, with Leading Players Syntegon, Gerresheimer, AptarGroup, Datwyler, Stevanato, OPTIMA, Bausch+Strobel, Groninger, SGD PHARMA, SCHOTT and Nipro
May 01, 2024 04:02 ET | Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Global Fill Finish Manufacturing Market by Product (Consumables (Pre-fillable Syringes (Plunger Stopper)), Vial (Glass, Plastic), Cartridge),...
EU Nephrologists For
EU Nephrologists Foresee Travere/CSL Vifor’s FILSPARITM (sparsentan) Transforming IgA Nephropathy Treatment as the First Non-Immunosuppressive Therapy
April 30, 2024 14:40 ET | Spherix Global Insights
EXTON, PA, April 30, 2024 (GLOBE NEWSWIRE) -- Over the past several years, glomerular diseases have garnered significant attention from the nephrology industry, largely driven by the persistent...
RS BioTherapeutics Logo.jpg
RS BioTherapeutics Launches Crowdfunding Campaign Through StartEngine
April 30, 2024 10:00 ET | RS BioTherapeutics
RS BioTherapeutics announced today the launch of an SEC Regulation Crowdfunding (Reg CF) investment campaign through StartEngine.